FDA ApprovalThe FDA approval of Zevtera for specific indications makes it the only approved MRSA cephalosporin antibiotic for certain infections, giving it a unique market position.
Product LaunchBasilea's antibiotic Zevtera is being launched in the U.S. ahead of schedule, offering potential for early revenue generation from royalties and sales milestones.
Sales MilestoneCresemba has achieved a sales milestone in Japan and is the highest-selling branded antifungal agent worldwide, reflecting strong market performance.